67 Views | 43 Downloads
Jaffar M. Khan, BM, BCh.
Cardiovascular Branch, Division of Intramural Research, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Conflicts of Interest: VCB is a consultant for Edwards Lifesciences and for Abbott Vascular, and his employer has research contracts for clinical investigation of transcatheter aortic and mitral devices from Edwards Lifesciences, Abbott Vascular, Medtronic, St Jude Medical, and Boston Scientific. ABG is a proctor for Edwards Lifesciences, Medtronic, and Abbott Vascular. He is a consultant for Transmural Systems. TR is a consultant/proctor for Medtronic and Edwards Lifesciences. He has equity shares in Transmural Systems. RW—Advisory Board: Abbott Vascular, Amgen, Boston Scientific, Medtronic, Philips, Pi-Cardia Ltd., Cardioset; Consultant: Abbott Vascular, Amgen, Biosensors, Biotronik, Boston Scientific, Medtronic, Philips, Pi-Cardia Ltd., Cardioset; Grant Support: Abbott Vascular, AstraZeneca, Biosensors, Biotronik, Boston Scientific, Chiesi; Speakers Bureau: AstraZeneca, Chiesi; Investor: MedAlliance. JMK is a proctor for Edwards Lifesciences and Medtronic. JMK, TR, and RJL are co-inventors on patents, assigned to NIH, on catheter devices to lacerate valve leaflets. NHLBI has a collaborative research and development agreement with Edwards Lifesciences on transcatheter modification of the mitral valve. The other authors have no conflicts of interest to declare.
Supported by the Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, USA (Z01-HL006040).
2021 Annals of Cardiothoracic Surgery.